Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 576.93B | 548.13B | 510.77B | 445.32B | 405.69B | 483.80B |
Gross Profit | 227.69B | 223.86B | 199.65B | 175.95B | 162.27B | 194.71B |
EBITDA | 35.05B | 28.66B | 22.60B | 25.08B | 16.22B | 27.31B |
Net Income | 35.19B | -6.71B | -13.74B | 5.38B | 7.13B | 3.73B |
Balance Sheet | ||||||
Total Assets | 348.96B | 337.51B | 310.69B | 310.26B | 289.31B | 288.47B |
Cash, Cash Equivalents and Short-Term Investments | 43.74B | 48.59B | 42.69B | 46.72B | 52.24B | 53.30B |
Total Debt | 21.81B | 39.37B | 26.82B | 25.49B | 27.22B | 26.94B |
Total Liabilities | 235.46B | 241.28B | 208.49B | 192.60B | 179.46B | 192.09B |
Stockholders Equity | 106.82B | 88.08B | 96.24B | 111.99B | 102.76B | 87.51B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 3.54B | 4.10B | 572.00M | 126.00M | 8.09B |
Operating Cash Flow | 0.00 | 19.41B | 15.11B | 10.04B | 9.24B | 20.75B |
Investing Cash Flow | 0.00 | -16.14B | -12.12B | -14.18B | -9.57B | -13.84B |
Financing Cash Flow | 0.00 | -3.62B | -8.10B | -5.50B | -4.31B | -7.05B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | €165.65B | 15.25 | 10.97% | 2.67% | 7.11% | -0.27% | |
75 Outperform | ¥102.56B | 14.09 | 2.79% | 8.95% | 4.60% | ||
73 Outperform | ¥161.52B | 5.19 | 30.22% | 1.70% | 5.27% | ― | |
71 Outperform | ¥91.87B | 21.42 | 4.86% | 0.03% | -23.96% | ||
70 Outperform | ¥3.94T | 22.83 | 3.91% | 9.08% | -33.61% | ||
70 Outperform | ¥603.17B | 11.17 | 6.70% | 3.93% | 3.72% | 6.12% | |
69 Neutral | ¥229.55B | 14.48 | 7.64% | 2.71% | 9.13% | 8.50% |